You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 168 No. 4, February 25, 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Drug Therapy, Other
 •Bacterial Infections
 •Neurology
 •Dementias
 •Aging/ Geriatrics
 •Alert me on articles by topic

Patterns of Antimicrobial Use Among Nursing Home Residents With Advanced Dementia

Erika D’Agata, MD, MPH; Susan L. Mitchell, MD, MPH

Arch Intern Med. 2008;168(4):357-362.

Background  Nursing home residents with advanced dementia are at high risk of infections and antimicrobial exposure near the end of life. Detailed studies quantifying antimicrobial prescribing practices among these residents have not been performed.

Methods  A cohort of 214 residents with advanced dementia from 21 Boston-area nursing homes were followed up prospectively for 18 months or until death. We analyzed antimicrobial use, including type, indication, and quantity, by days of therapy per 1000 resident-days.

Results  During an average of 322 days of follow-up, 142 residents (66.4%) with advanced dementia received at least 1 course of antimicrobial therapy (mean [SD] number of courses per resident, 4.0 [3.7]). The mean (SD) number of days of therapy per 1000 resident-days for the entire cohort was 53.0 (4.3). Quinolones and third-generation cephalosporins were the most commonly prescribed antimicrobials, accounting for 38.3% and 15.2%, respectively, of 540 prescribed antimicrobial therapy courses. A respiratory tract infection was the most common indication (46.7% of all antimicrobial therapy courses). Among 99 decedents, 42 (42.4%) received antimicrobials during the 2 weeks before death, of which 30 of 72 courses (41.7%) were administered via the parenteral route. The number of decedents receiving antimicrobials (P < .001), the number of antimicrobials prescribed (P = .01), and the days of therapy per 1000 resident-days (P < .001) increased significantly as subjects approached death.

Conclusions  Persons with advanced dementia are frequently exposed to antimicrobials, especially during the 2 weeks before death. The implications of this practice from the perspective of the individual treatment burden near the end of life and its contribution to the emergence of antimicrobial resistance in the nursing home setting need further evaluation.


Author Affiliations: Divisions of Infectious Diseases (Dr D’Agata) and Geriatrics (Dr Mitchell), Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School (Drs D’Agata and Mitchell), and Hebrew Senior Life Institute for Aging Research (Dr Mitchell), Boston, Massachusetts.


RELATED ARTICLE

Antibiotic Therapy in the Demented Elderly Population: Redefining the Ethical Dilemma
Mitchell J. Schwaber and Yehuda Carmeli
Arch Intern Med. 2008;168(4):349-350.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

All you need to read in the other general journals
BMJ 2008;336:530-531.
FULL TEXT  

Antibiotic Therapy in the Demented Elderly Population: Redefining the Ethical Dilemma
Schwaber and Carmeli
Arch Intern Med 2008;168:349-350.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.